-
ACLA Comments on Request for Information Regarding the Physician Self-Referral Law
-
AIM Coalition Urges CMS to Strengthen Medicare Self-Referral Provisions to Support Transition to Value-Based Care
Proposed Changes to Stark Law – Including Narrowing the In-Office Ancillary Services Exception – Would Save Medicare at Least $3.3 Billion Over Next Decade Washington, ... Read More -
ACLA Urges Congressional Leaders to Advance New Regulatory Framework for Diagnostic Tests
In Comments to Congress, ACLA Cites Concerns with the FDA’s New Proposals for Diagnostic Reform Washington, D.C. – Today, the American Clinical Laboratory Association (ACLA) ... Read More -
ACLA Comments on FDA Technical Assistance on the Diagnostic Accuracy and Innovation Act
-
Diagnostic Reform Coalition Letter to the Hill regarding FDA Technical Assistance
-
U.S. House Ways and Means Health Subcommittee Hearing “Modernizing Stark Law to Ensure the Successful Transition from Volume to Value in the Medicare Program”
-
AIM Coalition Urges Policymakers to Strengthen Medicare Self-Referral Provisions to Advance Transition to Value-Based Care
Washington, D.C. – As policymakers explore solutions to further advance the transition to a value-based care delivery system, members of the Alliance for Integrity in ... Read More -
ACLA Best Practice Recommendation for Administrative and Clinical Patient Gender used for Laboratory Testing and Reporting
-
Laboratory Developed Tests: Ground Zero in the Push Towards Personalized Medicine
For the many patients who suffer from rare or complex conditions, the certainty that comes from knowing a diagnosis and moving forward with a treatment ... Read More -
Patient Advocates, Providers, Laboratories and Diagnostic Manufacturers Urge Congressional Leaders to Modernize Regulation of Clinical Diagnostics
More than 80 Groups Unite for the First Time to Call for Legislative Reform Washington, D.C. – Leading health care companies and organizations representing ... Read More
